vTv Therapeutics (VTVT) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $26.54, -3.81% vs the prior close of $27.59.
- Volume 11.80K shares, 0.2x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
VTVT slides 3.8% to $26.54, a 6-month low. Closed at $26.54, -3.81% vs the prior close of $27.59. Day range $25.94–$27.49, opened at $27.49.
VTVT daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — VTVT slides 3.8% to $26.54, a 6-month low
- Closed at $26.54, -3.81% vs the prior close of $27.59. Day range $25.94–$27.49, opened at $27.49.
- Volume was 11.80K shares, 0.2x its 50-day average of 50.04K — lighter than usual.
- Price is -15.7% vs its 50-day average ($31.49) and -22.3% vs its 200-day average ($34.16).
- 52-week range $19.50–$44.00; today's close sits at 29% of that range, 39.7% below the 52-week high.
Oct 15, 2026 — VTVT ends flat (+0.3%) to $27.59
- Closed at $27.59, +0.25% vs the prior close of $27.52. Day range $27.42–$28.87, opened at $27.80.
- Volume was 22.20K shares, 0.4x its 50-day average of 51.65K — lighter than usual.
- Price is -12.8% vs its 50-day average ($31.65) and -19.4% vs its 200-day average ($34.22).
- 52-week range $19.50–$44.00; today's close sits at 33% of that range, 37.3% below the 52-week high.
Oct 14, 2026 — VTVT dips 2.5% to $27.52, a 6-month low, 3 down days in a row
- Closed at $27.52, -2.52% vs the prior close of $28.23. Day range $27.49–$28.86, opened at $27.91.
- Volume was 20.10K shares, 0.4x its 50-day average of 52.52K — lighter than usual.
- Price is -13.4% vs its 50-day average ($31.78) and -19.7% vs its 200-day average ($34.27).
- 52-week range $19.50–$44.00; today's close sits at 33% of that range, 37.5% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — VTVT slides 7.3% to $28.23, a 6-month low
- Closed at $28.23, -7.32% vs the prior close of $30.46. Day range $27.87–$31.22, opened at $30.75.
- Volume was 41.80K shares, 0.8x its 50-day average of 55.10K.
- Price is -11.4% vs its 50-day average ($31.87) and -17.8% vs its 200-day average ($34.32).
- 52-week range $19.50–$44.00; today's close sits at 36% of that range, 35.8% below the 52-week high.
Oct 12, 2026 — VTVT dips 2.3% to $30.46
- Closed at $30.46, -2.31% vs the prior close of $31.18. Day range $30.28–$31.18, opened at $31.12.
- Volume was 17.10K shares, 0.3x its 50-day average of 57.50K — lighter than usual.
- Price is -4.7% vs its 50-day average ($31.96) and -11.4% vs its 200-day average ($34.37).
- 52-week range $19.50–$44.00; today's close sits at 45% of that range, 30.8% below the 52-week high.
Oct 9, 2026 — VTVT jumps 3.7% to $31.18
- Closed at $31.18, +3.66% vs the prior close of $30.08. Day range $30.10–$31.18, opened at $30.16.
- Volume was 12.80K shares, 0.2x its 50-day average of 58.56K — lighter than usual.
- Price is -2.5% vs its 50-day average ($32.00) and -9.4% vs its 200-day average ($34.40).
- 52-week range $19.50–$44.00; today's close sits at 48% of that range, 29.1% below the 52-week high.
Oct 8, 2026 — VTVT dips 3.0% to $30.08
- Closed at $30.08, -3.00% vs the prior close of $31.01. Day range $29.80–$31.22, opened at $31.03.
- Volume was 44.30K shares, 0.7x its 50-day average of 61.98K.
- Price is -6.1% vs its 50-day average ($32.03) and -12.6% vs its 200-day average ($34.43).
- 52-week range $19.50–$44.00; today's close sits at 43% of that range, 31.6% below the 52-week high.
Oct 7, 2026 — VTVT jumps 3.3% to $31.01
- Closed at $31.01, +3.26% vs the prior close of $30.03. Day range $29.86–$31.50, opened at $29.95.
- Volume was 26.10K shares, 0.4x its 50-day average of 63.48K — lighter than usual.
- Price is -3.3% vs its 50-day average ($32.05) and -10.0% vs its 200-day average ($34.46).
- 52-week range $19.50–$44.00; today's close sits at 47% of that range, 29.5% below the 52-week high.
Oct 6, 2026 — VTVT dips 1.0% to $30.03, 3 down days in a row
- Closed at $30.03, -0.99% vs the prior close of $30.33. Day range $29.55–$30.50, opened at $30.50.
- Volume was 27.90K shares, 0.4x its 50-day average of 64.19K — lighter than usual.
- Price is -6.3% vs its 50-day average ($32.05) and -12.9% vs its 200-day average ($34.48).
- 52-week range $19.50–$44.00; today's close sits at 43% of that range, 31.7% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
Oct 5, 2026 — VTVT dips 0.8% to $30.33
- Closed at $30.33, -0.79% vs the prior close of $30.57. Day range $30.29–$31.56, opened at $31.56.
- Volume was 14.90K shares, 0.2x its 50-day average of 67.41K — lighter than usual.
- Price is -5.4% vs its 50-day average ($32.07) and -12.1% vs its 200-day average ($34.50).
- 52-week range $19.50–$44.00; today's close sits at 44% of that range, 31.1% below the 52-week high.
Oct 2, 2026 — VTVT slides 4.0% to $30.57
- Closed at $30.57, -4.02% vs the prior close of $31.85. Day range $30.57–$32.32, opened at $32.20.
- Volume was 18.00K shares, 0.3x its 50-day average of 70.18K — lighter than usual.
- Price is -4.7% vs its 50-day average ($32.08) and -11.5% vs its 200-day average ($34.53).
- 52-week range $19.50–$44.00; today's close sits at 45% of that range, 30.5% below the 52-week high.
VTVT latest news & SEC filings
Every SEC filing by or about VTVT in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 8, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.03 — Amended its charter or bylaws / changed fiscal year.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $0 (prior year $0)
- Net income: -$13.05M (prior year -$6.05M) (loss widened vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 29, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Jun 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 29, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Things to know before you trade VTVT
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 13, 2026, Mar 10, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.34% (largest 7.3%).
- Liquidity: about 30.94K shares (≈$821.15K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $26.54 vs a range of $19.50–$44.00 (29% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 6, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
VTVT market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 27.49 | 27.49 | 25.94 | 26.54 | 11.80K |
| Oct 15, 2026 | 27.80 | 28.87 | 27.42 | 27.59 | 22.20K |
| Oct 14, 2026 | 27.91 | 28.86 | 27.49 | 27.52 | 20.10K |
| Oct 13, 2026 | 30.75 | 31.22 | 27.87 | 28.23 | 41.80K |
| Oct 12, 2026 | 31.12 | 31.18 | 30.28 | 30.46 | 17.10K |
| Oct 9, 2026 | 30.16 | 31.18 | 30.10 | 31.18 | 12.80K |
| Oct 8, 2026 | 31.03 | 31.22 | 29.80 | 30.08 | 44.30K |
| Oct 7, 2026 | 29.95 | 31.50 | 29.86 | 31.01 | 26.10K |
| Oct 6, 2026 | 30.50 | 30.50 | 29.55 | 30.03 | 27.90K |
| Oct 5, 2026 | 31.56 | 31.56 | 30.29 | 30.33 | 14.90K |
| Oct 2, 2026 | 32.20 | 32.32 | 30.57 | 30.57 | 18.00K |
| Oct 1, 2026 | 30.99 | 32.28 | 30.99 | 31.85 | 34.30K |
| Sep 30, 2026 | 30.11 | 31.14 | 29.98 | 30.84 | 30.90K |
| Sep 29, 2026 | 30.34 | 30.69 | 30.00 | 30.00 | 85.10K |
| Sep 28, 2026 | 29.75 | 31.45 | 29.67 | 30.52 | 111.90K |
| Sep 25, 2026 | 30.60 | 30.91 | 29.79 | 30.21 | 28.80K |
| Sep 24, 2026 | 30.57 | 31.57 | 30.24 | 30.73 | 18.00K |
| Sep 23, 2026 | 31.03 | 31.40 | 30.47 | 30.58 | 18.90K |
| Sep 22, 2026 | 31.32 | 32.38 | 31.07 | 31.10 | 11.20K |
| Sep 21, 2026 | 31.45 | 32.00 | 31.01 | 31.30 | 22.70K |
About vTv Therapeutics
vTv Therapeutics (VTVT) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in HIGH POINT, NC. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1641489.
VTVT board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| L.P. 667, | Director | Jun 29, 2026 |
| Srinivas Akkaraju | Director | Jun 29, 2026 |
| Fahed Al-Marzooqi | Director | Jun 29, 2026 |
| Bros. Advisors Lp Baker | Director | Jun 29, 2026 |
| Felix Baker | Director | Jun 29, 2026 |
| Julian Baker | Director | Jun 29, 2026 |
| Bros. Advisors (Gp) Llc Baker | Director | Jun 29, 2026 |
| Brothers Life Sciences Lp Baker | Director | Jun 29, 2026 |
| Anne M. Phillips | Director | Jun 29, 2026 |
| Paul J Sekhri | Pres, CEO and Exec Chairperson | Feb 18, 2026 |
| Daniel K Spiegelman | Director | Jun 29, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Paul J Sekhri | Pres, CEO and Exec Chairperson | Feb 18, 2026 |
| Michael Stephen Tung | EVP & CFO | Feb 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
VTVT financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $0 | $-26.97M | — | $-25.25M |
| Dec 31, 2024 | $1.02M | $-18.46M | — | $-25.31M |
| Dec 31, 2023 | $0 | $-20.25M | — | $-19.08M |
| Dec 31, 2022 | $2.02M | $-19.16M | — | $-16.02M |
| Dec 31, 2021 | $4.00M | $-12.99M | — | $-19.31M |
Latest balance sheet: total assets $87.59M, total liabilities $8.96M, cash $86.64M (as of Jun 30, 2026).
VTVT earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $34.61 |
| May 13, 2026 | 8-K Item 2.02 (results) | $31.67 |
| Mar 10, 2026 | 8-K Item 2.02 (results) | $35.02 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $25.47 |
| Aug 12, 2025 | 8-K Item 2.02 (results) | $14.49 |
| May 15, 2025 | 8-K Item 2.02 (results) | $22.41 |
| Mar 20, 2025 | 8-K Item 2.02 (results) | $17.60 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $13.91 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Mar 13, 2024 | 8-K Item 2.02 (results) | — |
| Feb 28, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on VTVT
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.